Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial.

By R. Glass. Jornal de Pediatria, 2005

687 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

A Pilot SMART for Developing an Adaptive Treatment Strategy for Adolescent Depression (2015, positive): “Other studies have found that increasing the number of psychotherapy sessions also increases response rates for patients receiving only psychotherapy (Clarke, Rohde, Lewinsohn, Hops, & Seeley, 1999; TADS Team, 2007).”
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015, background): “In recent studies in adolescents, greater efficacy for combined CBT and fluoxetine compared with either treatment alone (CBT not separating from placebo) was reported in one study (March et al., 2004), but three subsequent studies have found no benefit from combined treatment over an SSRI alone (Cla”
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. (2007, background): “…Rating Scale-Revised score e 28 [Poznanski and Mokros, 1995]), a more stringent and yet more clinically relevant outcome, ranged between 30% and 40% (Emslie et al., 1997, 2002 [rct]; Goodyer et al., 2007 [rct]; Kennard et al., 2006 [rct]; March et al., 2004 [rct]; Wagner et al., 2003 [rct]).”